Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pangenomic Health Inc C.NARA

Pangenomic Health Inc. is a precision health company. The Company has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support platform for health practitioners (MUJN). The Nara mobile app provides consumers with a knowledge base, which is based on individual's user profile, leveraging input from mental health questionnaires, drug treatment regimen, genomic sequencing analysis, as well as their protein and microbiome biomarker reports. The Mindleap platform provides a variety of tools and resources to help individuals understand and improve their inner wellness. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports.


CSE:NARA - Post by User

Pangenomic Health Inc > Cannacord is buying. Good sign
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(273)
•••
Comment by kegmanon Jan 06, 2023 10:42am
260 Views
Post# 35206762

RE:Cannacord is buying. Good sign

RE:Cannacord is buying. Good sign
House Positions for C:NARA from 20230106 to 20230106
House Bought $Val Ave Sold $Val Ave Net $Net
7 TD Sec 423,587 144,209 0.34 81,033 27,781 0.343 342,554 -116,428
33 Canaccord 367,700 125,604 0.342 47,500 16,350 0.344 320,200 -109,254
House Positions for C:NARA from 20230104 to 20230106
House Bought $Val Ave Sold $Val Ave Net $Net
7 TD Sec 1,675,173 541,156 0.323 510,609 166,077 0.325 1,164,564 -375,079
33 Canaccord 1,612,172 517,853 0.321 830,000 268,235 0.323 782,172 -249,618
Still buying and percentage is higher so far today.  The drum beat is picking up.  I am thinking .50 next week once the selling for the folks on the PP have paid for their shares.  GLTA.  Promo hasn't even kicked in form new firm in BC.  Have to get the word out, raise the price for the next financing as they gain traction and expand offerings even more.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities